Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma

Abstract

Birch pollen AIT demonstrated real-world benefits up to 6 years post-treatment cessation through significantly reduced AR and asthma medication intake, and significantly decreased risk of new-onset asthma medication use on-treatment.